Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nancy Thornberry currently holds 13,313 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Thornberry has been a net seller of DNLI stock. They have purchased $0 and sold $693.0K worth of shares.
Nancy Thornberry's most recent insider trade was on Jun 22, 2026, when they sold 13,313 shares at $0.00 per share.
Nancy Thornberry serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 17 insider transactions totaling $693.0K over their tenure at the company.
Nancy Thornberry holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Nancy Thornberry has shown a selling trading pattern, with $0 in total purchases and $693.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nancy Thornberry was on May 22, 2023, when they sold $519.8K worth of SDGR shares. This transaction involved 14,850 shares at $35.00 per share.
Nancy Thornberry currently owns 13,313 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nancy Thornberry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nancy Thornberry has 17 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Nancy Thornberry and 40,000+ other insiders.